| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC4 ABCF3 TOR4A LONP1 UBA7 ASCC3 HSPA7 ABCG5 DYNC1H1 ABCC1 DHX58 DYNC2H1 MSH3 CCT5 MYH14 DNAH17 MYO1F DDX3Y ATP5F1A | 8.48e-06 | 614 | 193 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | cysteine-S-conjugate N-acetyltransferase activity | 9.29e-05 | 2 | 193 | 2 | GO:0047198 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC4 ABCF3 TOR4A LONP1 ASCC3 HSPA7 ABCG5 DYNC1H1 ABCC1 DHX58 DYNC2H1 CCT5 DDX3Y ATP5F1A | 1.04e-04 | 441 | 193 | 14 | GO:0016887 |
| GeneOntologyCellularComponent | non-motile cilium | CDH23 ADGRV1 PTGS1 TBCC GALR3 PKD2L1 ALPK1 TIAM1 TTLL6 GUCY2D | 2.01e-05 | 196 | 200 | 10 | GO:0097730 |
| GeneOntologyCellularComponent | dendritic growth cone | 1.78e-04 | 12 | 200 | 3 | GO:0044294 | |
| GeneOntologyCellularComponent | late recombination nodule | 2.72e-04 | 3 | 200 | 2 | GO:0005715 | |
| GeneOntologyCellularComponent | axon | ACHE SRC VPS16 TAOK2 CYFIP1 KCNA6 SCN4A PREX1 DYNC1H1 VIM GRIK5 TXNRD2 ARMCX3 SPTBN4 TH TIAM1 MYH14 ELFN1 STAU2 LRP1 | 3.67e-04 | 891 | 200 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | matrilin complex | 5.40e-04 | 4 | 200 | 2 | GO:0120216 | |
| GeneOntologyCellularComponent | recombination nodule | 5.40e-04 | 4 | 200 | 2 | GO:0005713 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 8.04e-04 | 157 | 200 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | dendrite terminus | 8.72e-04 | 20 | 200 | 3 | GO:0044292 | |
| GeneOntologyCellularComponent | axonal growth cone | 8.91e-04 | 45 | 200 | 4 | GO:0044295 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 9.14e-04 | 78 | 200 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | cilium | ABCC4 BBS2 CDH23 ADGRV1 WDR54 PTGS1 STOML3 TBCC BRWD1 CFAP47 GALR3 DYNC2H1 PKD2L1 ALPK1 SPAG6 TIAM1 TTLL6 GUCY2D DNAH17 | 1.04e-03 | 898 | 200 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | basement membrane | 1.15e-03 | 122 | 200 | 6 | GO:0005604 | |
| Domain | HEAT | 2.33e-06 | 58 | 195 | 7 | IPR000357 | |
| Domain | HEAT | 1.02e-05 | 48 | 195 | 6 | PF02985 | |
| Domain | AAA | 2.07e-05 | 144 | 195 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 2.07e-05 | 144 | 195 | 9 | IPR003593 | |
| Domain | HEAT_type_2 | 2.47e-05 | 17 | 195 | 4 | IPR021133 | |
| Domain | HEAT_REPEAT | 9.03e-05 | 70 | 195 | 6 | PS50077 | |
| Domain | Cytoplasmic_FMR1-int | 1.08e-04 | 2 | 195 | 2 | IPR008081 | |
| Domain | FragX_IP | 1.08e-04 | 2 | 195 | 2 | PF05994 | |
| Domain | ARM-type_fold | DOHH ATR XPO6 EIF2B5 GCN1 UBR4 RANBP6 APOB SPAG6 ARMCX3 MROH1 PRKDC | 2.42e-04 | 339 | 195 | 12 | IPR016024 |
| Domain | - | 5.57e-04 | 222 | 195 | 9 | 1.25.10.10 | |
| Domain | BROMODOMAIN_1 | 5.81e-04 | 37 | 195 | 4 | PS00633 | |
| Domain | Spectrin_bsu | 6.42e-04 | 4 | 195 | 2 | IPR016343 | |
| Domain | DUF1394 | 6.42e-04 | 4 | 195 | 2 | IPR009828 | |
| Domain | Matrilin_ccoil | 6.42e-04 | 4 | 195 | 2 | SM01279 | |
| Domain | - | 6.42e-04 | 4 | 195 | 2 | 1.20.5.30 | |
| Domain | DUF1394 | 6.42e-04 | 4 | 195 | 2 | PF07159 | |
| Domain | Matrilin_ccoil | 6.42e-04 | 4 | 195 | 2 | PF10393 | |
| Domain | Matrilin_coiled-coil_trimer | 6.42e-04 | 4 | 195 | 2 | IPR019466 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 KMT2B MAN2B1 SPEG OBSCN TOR4A ZZEF1 PLEKHH3 TAOK2 XPO6 CSAD A4GALT MTMR3 SAC3D1 CACNA1H GCN1 PREX1 DYNC1H1 ENGASE LRFN1 NLRX1 UBR4 LAMB3 CEP192 GRIN2D TXNRD2 MST1R CELSR1 MROH1 SND1 TRIM28 PRKDC | 8.26e-14 | 1105 | 203 | 32 | 35748872 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EPPK1 VPS16 KARS1 CYFIP1 AGL TOMM34 ASCC3 GCN1 DYNC1H1 RBBP5 POGK UBR4 GRIK5 MSH3 PRPF8 ARCN1 AAAS SND1 TRIM28 STAU2 DDX3Y PRKDC ATP5F1A | 3.21e-11 | 704 | 203 | 23 | 29955894 |
| Pubmed | GALE EPPK1 KMT2B QSOX1 LONP1 KARS1 EIF2B5 TOMM34 HSD17B4 GCN1 DYNC1H1 ABCC1 RBBP5 UBR4 SAMD5 PRPF8 ARCN1 CCT5 MYH14 PRKDC ATP5F1A | 1.47e-09 | 711 | 203 | 21 | 33022573 | |
| Pubmed | KDM5B SPTBN2 STAB1 DGLUCY UBA7 MTMR3 HSD17B4 PREX1 DYNC1H1 AGAP2 BRWD1 RAD23B VIM SEMA4D VWF UBR4 APBA1 MSH3 PRPF8 ARCN1 SPTBN4 TIAM1 MYH14 LRP1 ANKRD36 PRKDC ZNF565 ATP5F1A | 2.24e-09 | 1285 | 203 | 28 | 35914814 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | KMT2B SPTBN2 OBSCN PIDD1 ZZEF1 PTGS1 TMCO4 KARS1 AGL DYNC1H1 CFAP47 RBBP5 UBR4 LAMB3 PCDHA5 GRIK5 PRPF8 ARCN1 DIPK2B PRKDC LYN | 2.71e-09 | 736 | 203 | 21 | 29676528 |
| Pubmed | EPPK1 PLEKHH3 QSOX1 KARS1 PYGL TOP1MT GCN1 HSPA7 DYNC1H1 VIM UBR4 PRPF8 COTL1 ARCN1 SND1 CCT5 MYH14 DDX3Y PRKDC ATP5F1A SMTNL2 | 2.89e-08 | 844 | 203 | 21 | 25963833 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ABCF3 TOR4A VPS16 LONP1 KARS1 CYFIP1 EIF2B5 PYGL ASCC3 GCN1 DYNC1H1 VIM UBR4 MSH3 PRPF8 COTL1 ARCN1 ZC3H7A AAAS SND1 CCT5 MYH14 TRIM28 AATF PRKDC ATP5F1A | 1.07e-07 | 1353 | 203 | 26 | 29467282 |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | KARS1 CYFIP1 GCN1 DYNC1H1 RAD23B VIM PRPF8 ARCN1 CCT5 TRIM28 PRKDC ATP5F1A | 1.14e-07 | 281 | 203 | 12 | 30455355 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATR LONP1 KARS1 CYFIP1 EIF2B5 HSD17B4 GCN1 DYNC1H1 RAD23B VIM RBBP5 DYNC2H1 UBR4 APOB MSH3 PRPF8 ARCN1 CYFIP2 AAAS SND1 CCT5 MYH14 TRIM28 PRKDC ATP5F1A DCAF7 | 2.91e-07 | 1425 | 203 | 26 | 30948266 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPPK1 SPTBN2 KARS1 CYFIP1 AGL PYGL ASCC3 GCN1 DYNC1H1 RAD23B VIM UBR4 PRPF8 COTL1 ARCN1 CYFIP2 SND1 CCT5 TRIM28 STAU2 PRKDC ATP5F1A DCAF7 | 3.05e-07 | 1149 | 203 | 23 | 35446349 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | THEM6 CYFIP1 AGL MTMR3 TOMM34 PYGL ASCC3 GCN1 RAD23B DTNB UBR4 DTL RANBP6 PRPF8 ARMCX3 AAAS CCT5 TRIM28 LRP1 PRKDC DCAF7 | 3.13e-07 | 974 | 203 | 21 | 28675297 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | L2HGDH BCKDHA KARS1 CYFIP1 AGL PYGL ASCC3 HSD17B4 GCN1 DYNC1H1 RAD23B VIM UBR4 DTL PRPF8 ARCN1 AAAS SND1 CCT5 TRIM28 DDX3Y PRKDC ATP5F1A DCAF7 | 3.88e-07 | 1257 | 203 | 24 | 37317656 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GALE EPPK1 ABCF3 KARS1 CYFIP1 AGL TOMM34 PYGL HSD17B4 GCN1 RAD23B VIM UBR4 MUC5B PRPF8 COTL1 ARCN1 AAAS SND1 CCT5 STAU2 LRP1 AATF PRKDC ATP5F1A | 4.81e-07 | 1367 | 203 | 25 | 32687490 |
| Pubmed | VPS16 LONP1 KARS1 EIF2B5 PYGL ASCC3 GCN1 DYNC1H1 UBR4 LAMB3 PRPF8 ARCN1 ZC3H7A MYH14 PRKDC ATP5F1A | 5.73e-07 | 601 | 203 | 16 | 33658012 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 7.25e-07 | 219 | 203 | 10 | 31353912 | |
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 29309644 | ||
| Pubmed | CDR2 MAN2B1 SYNJ2BP OBSCN BCKDHA LONP1 KARS1 HSD17B4 ABCC1 P4HA2 PAM16 TXNRD2 ARMCX3 ARCN1 CYFIP2 SND1 P3H2 LRP1 ATP5F1A | 8.07e-07 | 859 | 203 | 19 | 31536960 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DOHH BCKDHA LONP1 KARS1 PYGL ASCC3 TOP1MT HSD17B4 GCN1 DYNC1H1 VIM UBR4 PRPF8 ARCN1 SND1 CCT5 TRIM28 STAU2 DDX3Y AATF PRKDC LYN ATP5F1A DCAF7 | 8.96e-07 | 1318 | 203 | 24 | 30463901 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPPK1 ATR SPTBN2 KARS1 GCN1 DYNC1H1 VIM PRPF8 ARCN1 SND1 CCT5 TRIM28 PRKDC ATP5F1A | 9.56e-07 | 477 | 203 | 14 | 31300519 |
| Pubmed | SPTBN2 CCNO MEN1 DGAT2 SCN4A TOP1MT HSD17B4 PREX1 AGAP2 VIM PCDHGA5 DTNB UBR4 DTL APOB PRPF8 CYFIP2 SPTBN4 ZC3H7A SND1 MYH14 AATF PABPC1L PRKDC ATP5F1A | 1.27e-06 | 1442 | 203 | 25 | 35575683 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | LONP1 KARS1 AGL PYGL GCN1 DYNC1H1 VIM PRPF8 SND1 CCT5 PRKDC LYN ATP5F1A | 1.38e-06 | 422 | 203 | 13 | 27342126 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPPK1 ZZEF1 BRPF1 GCN1 DYNC1H1 VIM DYNC2H1 UBR4 MUC5B PRPF8 ARCN1 CYFIP2 SND1 CCT5 MYH14 TRIM28 PRKDC ATP5F1A | 1.42e-06 | 807 | 203 | 18 | 30575818 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | EPPK1 TOR4A MEN1 PYGL HSD17B4 DYNC1H1 VIM UBR4 LAMB3 ARCN1 CCT5 MYH14 TRIM28 PABPC1L PRKDC ATP5F1A | 1.50e-06 | 647 | 203 | 16 | 26618866 |
| Pubmed | 1.94e-06 | 5 | 203 | 3 | 12393736 | ||
| Pubmed | 1.97e-06 | 99 | 203 | 7 | 19730683 | ||
| Pubmed | SPTBN2 TAOK2 CYFIP1 DYNC1H1 AGAP2 GRIK5 GRIN2D CYFIP2 SPTBN4 LRP1 | 2.48e-06 | 251 | 203 | 10 | 27507650 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 2.74e-06 | 104 | 203 | 7 | 36055981 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TAOK2 THEM6 KARS1 XPO6 EIF2B5 FAM20B ASCC3 GCN1 DYNC1H1 ABCC1 DYNC2H1 SGSH UBR4 DTL RANBP6 ARCN1 AAAS SND1 PRKDC | 3.10e-06 | 942 | 203 | 19 | 31073040 |
| Pubmed | EPPK1 THEM6 HSD17B4 GCN1 DYNC1H1 VIM LRFN1 PRPF8 AAAS SND1 CCT5 PRKDC ATP5F1A | 3.82e-06 | 463 | 203 | 13 | 34901782 | |
| Pubmed | SPTBN2 L2HGDH BCKDHA THEM6 LONP1 KARS1 EIF2B5 ASCC3 GCN1 DYNC1H1 ABCC1 DHX58 RBBP5 UBR4 RANBP6 PRPF8 ARCN1 AAAS SND1 CCT5 TRIM28 STAU2 PRKDC ATP5F1A | 4.11e-06 | 1440 | 203 | 24 | 30833792 | |
| Pubmed | ABCC4 L2HGDH LONP1 HSD17B4 GCN1 HSPA7 DYNC1H1 VIM ABCC1 PRPF8 ARCN1 PRMT6 CCT5 TRIM28 DDX3Y PRKDC QRSL1 ATP5F1A | 4.57e-06 | 878 | 203 | 18 | 37223481 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 KARS1 GCN1 DYNC1H1 UBR4 MSH3 PRPF8 SND1 CCT5 TRIM28 PRKDC | 4.59e-06 | 332 | 203 | 11 | 32786267 |
| Pubmed | MAN2B1 EIF2B5 GCN1 RAD23B VIM UBR4 RANBP6 PRPF8 ARCN1 TRIM28 PRKDC ATP5F1A | 5.68e-06 | 408 | 203 | 12 | 33766124 | |
| Pubmed | 5.88e-06 | 164 | 203 | 8 | 32409323 | ||
| Pubmed | LONP1 KARS1 CYFIP1 ASCC3 HSD17B4 GCN1 DYNC1H1 VIM UBR4 PRPF8 ARCN1 SND1 CCT5 TRIM28 PRKDC | 5.90e-06 | 638 | 203 | 15 | 33239621 | |
| Pubmed | 6.24e-06 | 21 | 203 | 4 | 16079250 | ||
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | CYFIP1 PYGL GCN1 DYNC1H1 VIM CCT5 TRIM28 DDX3Y PRKDC ATP5F1A DCAF7 | 6.42e-06 | 344 | 203 | 11 | 36282215 |
| Pubmed | Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated signaling. | 6.74e-06 | 7 | 203 | 3 | 11389024 | |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | ATR PTGS1 MEN1 ASCC3 TOP1MT HSD17B4 RAD23B ABCC1 MSH3 RGS6 GUCY2D | 7.76e-06 | 351 | 203 | 11 | 20453000 |
| Pubmed | EPPK1 SPTBN2 LONP1 KARS1 PYGL ASCC3 GCN1 DYNC1H1 UBR4 PRPF8 SND1 CCT5 MYH14 AATF PRKDC | 7.77e-06 | 653 | 203 | 15 | 22586326 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 ABCF3 ATR STAB1 XPO6 GCN1 DYNC1H1 VIM RBBP5 PRPF8 ARCN1 SND1 CCT5 PRKDC | 9.40e-06 | 582 | 203 | 14 | 20467437 |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 9.47e-06 | 175 | 203 | 8 | 25756610 | |
| Pubmed | KDM5B DOHH KARS1 XPO6 GCN1 RANBP6 APOB PRMT6 SND1 TTLL6 TRIM28 ATP5F1A | 1.01e-05 | 432 | 203 | 12 | 7671812 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 SPTBN2 SRC LONP1 ASCC3 HSD17B4 GCN1 DYNC1H1 PRPF8 ARCN1 AAAS SND1 CCT5 MYH14 TRIM28 AATF PRKDC LYN ATP5F1A | 1.01e-05 | 1024 | 203 | 19 | 24711643 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDR2 BBS2 CDH23 BCKDHA THEM6 LONP1 KARS1 CYFIP1 XPO6 EIF2B5 PYGL GCN1 DYNC1H1 VIM P4HA2 LRFN1 DYNC2H1 PAM16 PRPF8 TIAM1 SND1 DCAF7 | 1.08e-05 | 1321 | 203 | 22 | 27173435 |
| Pubmed | 1.25e-05 | 87 | 203 | 6 | 12465718 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPPK1 MATN2 SPTBN2 KARS1 TOP1MT HSPA7 DYNC1H1 VIM APOB PRPF8 SND1 CCT5 MYH14 TRIM28 DDX3Y AATF PRKDC ATP5F1A | 1.31e-05 | 949 | 203 | 18 | 36574265 |
| Pubmed | 1.33e-05 | 241 | 203 | 9 | 23125841 | ||
| Pubmed | SPTBN2 BCKDHA LONP1 MTMR11 KARS1 MTMR3 PHLPP1 HSD17B4 GCN1 VIM ABCC1 DTNB CEP192 CYFIP2 AAAS TIAM1 CCT5 AATF ATP5F1A | 1.42e-05 | 1049 | 203 | 19 | 27880917 | |
| Pubmed | SPTBN2 SRC TAOK2 CYFIP1 DYNC1H1 AGAP2 VIM LRFN1 UBR4 GRIK5 GRIN2D CYFIP2 SPTBN4 RGS6 TRIM28 LRP1 DCAF7 PHACTR1 | 1.59e-05 | 963 | 203 | 18 | 28671696 | |
| Pubmed | ABCF3 MAN2B1 PTGS1 KARS1 GCN1 VIM SGSH PRPF8 CCT5 TRIM28 LRP1 DDX3Y PRKDC ATP5F1A | 1.67e-05 | 613 | 203 | 14 | 22268729 | |
| Pubmed | ABCC4 ABCF3 LONP1 TOMM34 ASCC3 GCN1 DYNC1H1 AGAP2 ABCC1 UBR4 MSH3 PRPF8 ARCN1 CYFIP2 AAAS MYH14 STAU2 DDX3Y PRKDC ATP5F1A | 1.87e-05 | 1168 | 203 | 20 | 19946888 | |
| Pubmed | Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination. | 2.07e-05 | 28 | 203 | 4 | 35227662 | |
| Pubmed | Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. | 2.28e-05 | 10 | 203 | 3 | 19826009 | |
| Pubmed | KMT2B SPTBN2 CYFIP1 ASCC3 GCN1 DYNC1H1 VIM ARCN1 SND1 CCT5 TRIM28 PRKDC DCAF7 | 2.32e-05 | 549 | 203 | 13 | 38280479 | |
| Pubmed | LONP1 KARS1 ASCC3 HSD17B4 GCN1 DYNC1H1 VIM PRPF8 ARCN1 CYFIP2 SND1 CCT5 TRIM28 TSPAN10 PRKDC ATP5F1A | 2.43e-05 | 809 | 203 | 16 | 32129710 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | EPPK1 CCNO LONP1 HSPA7 UBR4 CEP192 GRIN2D PRPF8 ARMCX3 CCT5 TRIM28 PRKDC ATP5F1A DCAF7 | 2.64e-05 | 639 | 203 | 14 | 23443559 |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 2.74e-05 | 264 | 203 | 9 | 32814769 | |
| Pubmed | 2.74e-05 | 30 | 203 | 4 | 32867711 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC4 MAN2B1 ATR MATN2 ZZEF1 PTGS1 THEM6 XPO6 A4GALT FAM20B ABCC1 P4HA2 SGSH RANBP6 LAMB3 MST1R CELSR1 TRIM28 P3H2 LRP1 | 2.77e-05 | 1201 | 203 | 20 | 35696571 |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 2.90e-05 | 333 | 203 | 10 | 32665550 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 3.12e-05 | 11 | 203 | 3 | 17607528 | |
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 3.13e-05 | 31 | 203 | 4 | 20516061 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 25301944 | ||
| Pubmed | Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma. | 3.39e-05 | 2 | 203 | 2 | 24024181 | |
| Pubmed | DNA structure-specific priming of ATR activation by DNA-PKcs. | 3.39e-05 | 2 | 203 | 2 | 23897887 | |
| Pubmed | Genetic analysis of the cytoplasmic dynein subunit families. | 3.39e-05 | 2 | 203 | 2 | 16440056 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 9353253 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 23612011 | ||
| Pubmed | Roles of ABCC1 and ABCC4 in Proliferation and Migration of Breast Cancer Cell Lines. | 3.39e-05 | 2 | 203 | 2 | 33081264 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 15185077 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 28594978 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 30486550 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 25502651 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 34327661 | ||
| Pubmed | Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes. | 3.39e-05 | 2 | 203 | 2 | 10577906 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 37748077 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 31324746 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 15820310 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 16166096 | ||
| Pubmed | Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia. | 3.39e-05 | 2 | 203 | 2 | 38128786 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 24642750 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 7550320 | ||
| Pubmed | Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism. | 3.39e-05 | 2 | 203 | 2 | 29752658 | |
| Pubmed | Epistasis between the HSD17B4 and TG polymorphisms is associated with premature ovarian failure. | 3.39e-05 | 2 | 203 | 2 | 22265031 | |
| Pubmed | Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins. | 3.39e-05 | 2 | 203 | 2 | 20530583 | |
| Pubmed | Role of Src-family kinases in formation of the cortical actin cap at the dorsal cell surface. | 3.39e-05 | 2 | 203 | 2 | 18457834 | |
| Pubmed | Regulation of DNA-dependent protein kinase by the Lyn tyrosine kinase. | 3.39e-05 | 2 | 203 | 2 | 9748231 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 24333487 | ||
| Pubmed | C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. | 3.39e-05 | 2 | 203 | 2 | 24357318 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 25057902 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 33846551 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 35567753 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 24130369 | ||
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | L2HGDH BCKDHA DGLUCY LONP1 KARS1 TOMM34 TOP1MT HSD17B4 DNAJC4 NLRX1 PAM16 TXNRD2 SND1 FARS2 QRSL1 ATP5F1A PRODH | 3.44e-05 | 926 | 203 | 17 | 20877624 |
| Pubmed | LONP1 TOMM34 GCN1 DYNC1H1 VIM UBR4 PRPF8 ARCN1 SND1 CCT5 TRIM28 PRKDC | 3.54e-05 | 491 | 203 | 12 | 22623428 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 3.64e-05 | 211 | 203 | 8 | 24097068 | |
| Pubmed | 3.72e-05 | 64 | 203 | 5 | 22865885 | ||
| Pubmed | KARS1 AGL PYGL GCN1 CFAP47 RBBP5 AAAS SND1 CCT5 MYH14 TRIM28 DCAF7 | 3.76e-05 | 494 | 203 | 12 | 26831064 | |
| Pubmed | 3.87e-05 | 276 | 203 | 9 | 28319085 | ||
| Interaction | TOP3B interactions | EPPK1 KMT2B MAN2B1 SPEG SPTBN2 OBSCN TOR4A ZZEF1 PLEKHH3 TAOK2 LONP1 KARS1 XPO6 CSAD A4GALT MTMR3 SAC3D1 CACNA1H GCN1 PREX1 DYNC1H1 ENGASE LRFN1 NLRX1 UBR4 APBA1 LAMB3 APOB CEP192 MSH3 GRIN2D TXNRD2 MST1R ZC3H7A CELSR1 MROH1 SND1 TRIM28 PRKDC LYN | 4.87e-09 | 1470 | 201 | 40 | int:TOP3B |
| Interaction | FLT3 interactions | EPPK1 CT47A1 SRC DGLUCY LONP1 KARS1 HSD17B4 GCN1 ABCG5 DYNC1H1 UBR4 PCDHA5 APOB ASMT PRKDC LYN | 1.34e-07 | 318 | 201 | 16 | int:FLT3 |
| Interaction | AURKB interactions | EPPK1 MAN2B1 ADGRV1 ZZEF1 MEN1 LONP1 AGL BRD1 GCN1 HSPA7 DYNC1H1 VIM UBR4 DTL THTPA CEP192 MYH14 TRIM28 TSPAN10 MYO1F PABPC1L PRKDC ATP5F1A DCAF7 | 6.51e-07 | 761 | 201 | 24 | int:AURKB |
| Interaction | KIF20A interactions | CAPN12 EPPK1 SPTBN2 STAB1 LONP1 EIF2B5 PHLPP1 TOP1MT HSD17B4 GCN1 HSPA7 KLB VIM P4HA2 DYNC2H1 APOB PRPF8 SPTBN4 AAAS MYH14 TSPAN10 ELFN1 MYO1F PABPC1L PRKDC LYN ATP5F1A | 6.31e-06 | 1052 | 201 | 27 | int:KIF20A |
| Interaction | CA14 interactions | 6.85e-06 | 71 | 201 | 7 | int:CA14 | |
| Interaction | MAP2K7 interactions | LONP1 BRD1 GCN1 DYNC1H1 PCDHGA5 CYFIP2 LRP1 PRKDC PRODH DCAF7 | 2.98e-05 | 197 | 201 | 10 | int:MAP2K7 |
| Interaction | MTTP interactions | 3.31e-05 | 19 | 201 | 4 | int:MTTP | |
| GeneFamily | Neuroblastoma breakpoint family | 2.50e-05 | 23 | 137 | 4 | 662 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 3.20e-04 | 18 | 137 | 3 | 498 | |
| GeneFamily | PHD finger proteins | 6.09e-04 | 90 | 137 | 5 | 88 | |
| GeneFamily | Pseudoautosomal region 1|Solute carriers | 8.66e-04 | 25 | 137 | 3 | 715 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.93e-04 | 206 | 137 | 7 | 682 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.17e-03 | 7 | 137 | 2 | 1113 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP | MAN2B1 LONP1 ENGASE NAT8 ALPK1 COTL1 AAAS TIAM1 SND1 DDX3Y ATP5F1A | 4.29e-07 | 199 | 201 | 11 | M9918 |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | GALE ACHE MTMR11 DGAT2 GLTPD2 ABCG5 COL17A1 LAMB3 APOB MYH14 LRP1 PRODH | 8.38e-07 | 259 | 201 | 12 | M40029 |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN | MAN2B1 ZZEF1 STAB1 CLEC11A EIF2B5 SGSH PRPF8 TRIM28 MYO1F ZBED1 | 3.57e-06 | 200 | 201 | 10 | M5977 |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | EPPK1 MAN2B1 PTGS1 STAB1 QSOX1 CYFIP1 CLEC11A PYGL HSD17B4 HSPA7 VWF DYNC2H1 APBA1 LAMB3 COTL1 CELSR1 TENM4 P2RY2 LRP1 | 4.72e-06 | 740 | 201 | 19 | M41202 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | MAN2B1 SYNJ2BP CDH23 VPS16 WDR54 ZZEF1 DGLUCY UBA7 XPO6 CSAD HSPA7 ENGASE UBR4 CEP192 TXNRD2 COTL1 NBPF10 PABPC1L ANKRD36 FUT4 LYN | 6.96e-06 | 905 | 201 | 21 | M40865 |
| Coexpression | SESTO_RESPONSE_TO_UV_C6 | 1.18e-05 | 39 | 201 | 5 | M4229 | |
| Coexpression | GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN | 1.38e-05 | 185 | 201 | 9 | M8238 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | EPPK1 MATN2 BBS2 FBXO17 CACNA1H TOP1MT ABCC1 SPAG6 ARMCX3 TG FUT4 | 1.46e-05 | 287 | 201 | 11 | M6510 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | SPEG PTGS1 TAOK2 XPO6 A4GALT TOMM34 PYGL YDJC CACNA1H ABCC1 P4HA2 SGSH NLRX1 NBPF20 NOL4L NACC2 ELFN1 P3H2 STAU2 SMTNL2 PHACTR1 | 1.56e-05 | 955 | 201 | 21 | M45680 |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | EPPK1 MATN2 BBS2 FBXO17 CACNA1H TOP1MT ABCC1 SPAG6 ARMCX3 TG FUT4 | 2.01e-05 | 297 | 201 | 11 | MM1003 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | EPPK1 SPEG MATN4 ADGRV1 FBXO17 TMCO4 HENMT1 KCNA6 FAM83G ACP7 NLRX1 SPAG6 SPTBN4 GUCY2D FUT4 | 2.17e-05 | 544 | 201 | 15 | M1936 |
| Coexpression | GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN | 2.46e-05 | 199 | 201 | 9 | M8197 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_DN | 2.56e-05 | 200 | 201 | 9 | M4938 | |
| Coexpression | GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN | 2.56e-05 | 200 | 201 | 9 | M5088 | |
| Coexpression | GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN | 2.56e-05 | 200 | 201 | 9 | M5286 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | EPPK1 SPEG MATN4 ADGRV1 FBXO17 TMCO4 HENMT1 KCNA6 FAM83G ACP7 NLRX1 SPAG6 SPTBN4 GUCY2D FUT4 | 4.01e-05 | 574 | 201 | 15 | MM820 |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN | 1.37e-04 | 195 | 201 | 8 | M4292 | |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_DN | 1.37e-04 | 195 | 201 | 8 | M3117 | |
| Coexpression | GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN | 1.42e-04 | 196 | 201 | 8 | M4433 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP | 1.58e-04 | 199 | 201 | 8 | M9351 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | 1.58e-04 | 199 | 201 | 8 | M4350 | |
| Coexpression | GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN | 1.63e-04 | 200 | 201 | 8 | M8651 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP | 1.63e-04 | 200 | 201 | 8 | M3852 | |
| Coexpression | GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN | 1.63e-04 | 200 | 201 | 8 | M4298 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_DC_DN | 1.63e-04 | 200 | 201 | 8 | M4492 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-07 | 192 | 202 | 9 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-07 | 192 | 202 | 9 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.58e-07 | 193 | 202 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 168 | 202 | 8 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 168 | 202 | 8 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 168 | 202 | 8 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-06 | 173 | 202 | 8 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-06 | 173 | 202 | 8 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-mesenchymal_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.36e-06 | 121 | 202 | 7 | 176de42c088988fe1a7838f96add26ee8a30e543 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 1.40e-06 | 175 | 202 | 8 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | severe-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.53e-06 | 177 | 202 | 8 | d1ad35ee3d2a84b1d01126d0a38464ab858c00d0 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 186 | 202 | 8 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 186 | 202 | 8 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 188 | 202 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | facs-Brain_Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 191 | 202 | 8 | bf1135b382a3bf8cddc19538bc38361ef1fc2de1 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-06 | 196 | 202 | 8 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-06 | 196 | 202 | 8 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.39e-06 | 197 | 202 | 8 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-06 | 199 | 202 | 8 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 3.79e-06 | 200 | 202 | 8 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | COVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.79e-06 | 200 | 202 | 8 | 621af09aae34226902c03edf556562f3ab35a7d8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.79e-06 | 200 | 202 | 8 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-06 | 200 | 202 | 8 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.79e-06 | 200 | 202 | 8 | e57452b73abb21cb3f645d45523ab93f6bef0243 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.92e-06 | 151 | 202 | 7 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 164 | 202 | 7 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 164 | 202 | 7 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.38e-05 | 172 | 202 | 7 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.38e-05 | 172 | 202 | 7 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 172 | 202 | 7 | 65b8935a972bf00b7a10dc2d442128fc0ed78bcb | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.50e-05 | 116 | 202 | 6 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-05 | 176 | 202 | 7 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.07e-05 | 183 | 202 | 7 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 2.14e-05 | 184 | 202 | 7 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-05 | 184 | 202 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-05 | 185 | 202 | 7 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.29e-05 | 186 | 202 | 7 | 37b93ebd64ebbd08193a746e5bc9b350c2570733 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-05 | 186 | 202 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.37e-05 | 187 | 202 | 7 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 187 | 202 | 7 | f1e9877d859369b862d4a559ec9ab9be74a67a96 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 187 | 202 | 7 | 3ffbd50b49059dcd3e23c5ac01901e4352142446 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.46e-05 | 188 | 202 | 7 | 59d5c7b147af118442adadf708ce2d1422b1e9aa | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-05 | 188 | 202 | 7 | 137ed9958044fab7a13648affb469585d1c48cf6 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-05 | 188 | 202 | 7 | 8ffb5394f7b00ea483a5fe4df894d22fda935e5c | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.46e-05 | 188 | 202 | 7 | 2e268d8091e25d50bf05f26517d3ceb583801fd4 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-05 | 188 | 202 | 7 | c2febf9fd4632af1f922067c3a30e5c50f75f480 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.54e-05 | 189 | 202 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 189 | 202 | 7 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 189 | 202 | 7 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 190 | 202 | 7 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 190 | 202 | 7 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 190 | 202 | 7 | 888ded899f0513d41bf655896d59ae8ef74e0978 | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 2.72e-05 | 191 | 202 | 7 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 191 | 202 | 7 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | 5'|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.72e-05 | 191 | 202 | 7 | 0e752756e9d1b444930522efc0fdca072d42535f | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 191 | 202 | 7 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 191 | 202 | 7 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 191 | 202 | 7 | 116fba9badea093e11f370996247cca0e4c02e8f | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 191 | 202 | 7 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-05 | 192 | 202 | 7 | 13e4b17d7a592604140777aca235f795df6b3f91 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-05 | 192 | 202 | 7 | 6244541688f85917018a057aa0b3e5972934dfbc | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-05 | 192 | 202 | 7 | f51b3fd962263920a6cae783ca7af13f5eb7aaa3 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.81e-05 | 192 | 202 | 7 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | facs-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 192 | 202 | 7 | cca2d0fedfbd946c54d6f4fc45887117c8dae58a | |
| ToppCell | facs-Trachea-24m-Epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.90e-05 | 193 | 202 | 7 | ec49a83b24371579d4ad46aad91c25115aa226f9 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.00e-05 | 194 | 202 | 7 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-immature_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 132 | 202 | 6 | 9936078c328b1e1d59f9dfdd69d36926a0cdaf0d | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 3.31e-05 | 197 | 202 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 3.31e-05 | 197 | 202 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.31e-05 | 197 | 202 | 7 | 3cd1c816bc7a57278b2ef615b69545356ab8f522 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.42e-05 | 198 | 202 | 7 | feac39036b5c0ab97b524cc366286942d136d42f | |
| ToppCell | Bronchial_Brush-Epithelial-Club|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.42e-05 | 198 | 202 | 7 | 61292a2b5aacb6080a679a31b70a211bdec59a3b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.42e-05 | 198 | 202 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.42e-05 | 198 | 202 | 7 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.53e-05 | 199 | 202 | 7 | 372fb9eb90022dc4ac770a75b4e207c33d1d0c43 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 199 | 202 | 7 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Bronchial_Brush-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.53e-05 | 199 | 202 | 7 | 53b87edccc89a3e8a6c5166472f9ef24fcba416c | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.53e-05 | 199 | 202 | 7 | dd3bf59cdc18091889cbf6c43f37100ba537843d | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 3.53e-05 | 199 | 202 | 7 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.64e-05 | 200 | 202 | 7 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | COVID_vent-Myeloid-Monocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.64e-05 | 200 | 202 | 7 | b0a5bee87700ce38f26f95a6f491da7e27cade51 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 200 | 202 | 7 | 8872d5fa101d413fb43b4231d476878678543035 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.64e-05 | 200 | 202 | 7 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 4.25e-05 | 85 | 202 | 5 | 3f33e897eb030043905a6a1a83377cd601652958 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.87e-05 | 143 | 202 | 6 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.07e-05 | 144 | 202 | 6 | 748f4efc59f7afbce6c497524f36d852b8b1d637 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.60e-05 | 90 | 202 | 5 | 27865bd63dda0624e62a3b713464a490b588d3ae | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.60e-05 | 90 | 202 | 5 | 8c2eb7444f938faade7c81a60c004252d588c80b | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.60e-05 | 90 | 202 | 5 | 4bc53b521abb79fc53ac912f1dc2e3c55426b2e0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.13e-05 | 149 | 202 | 6 | 1e77f03d2b32f366018fec3462d1b75f6e7febb9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 156 | 202 | 6 | 0695ac0f02d059ecf813d61d3c9d4c76d1d85834 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 156 | 202 | 6 | 1c2920f4356789a9c11d5ea1eaafb18a50b19ed7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 156 | 202 | 6 | a45fbe02cd03bd4a097f21368bc1179779ba0db8 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-05 | 158 | 202 | 6 | 1e7bf5f51a6582026b844095fc11434430a83dab | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.08e-05 | 160 | 202 | 6 | 741e3b3f4ec5c77752da54746451f332435226e3 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.08e-05 | 160 | 202 | 6 | 5cc1b75e3c20d83112b3aa2f3c749a6c73910a2d | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-05 | 101 | 202 | 5 | 6c4524be89cf3eb06769c2963dcded3da1e71ca0 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-05 | 162 | 202 | 6 | ca1014e32996f777bff021830ce9a7cf4acf58d5 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 1.01e-04 | 163 | 202 | 6 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 164 | 202 | 6 | 29da0175bd3808a5b3039a6161c764105608ef96 | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | CCNO PTGS1 TAOK2 MTMR3 CACNA1H NLRX1 TG ZNF3 DNAH17 SYNGR1 FUT4 | 1.59e-06 | 199 | 200 | 11 | 3978_DN |
| Disease | cortical thickness | ABCF3 KMT2B SPTBN2 ADGRV1 STAB1 FZD9 DENND1B MTMR3 RAD23B SEMA4D P4HA2 GALR3 MSH3 TG NOL4L CELSR1 SND1 TSPAN10 STAU2 LRP1 | 5.27e-05 | 1113 | 195 | 20 | EFO_0004840 |
| Disease | Prostatic Neoplasms | ABCC4 ATR ACHE MATN4 BRPF1 ABCG5 RAD23B VIM MSH3 TXNRD2 AAAS MYH14 PRKDC ZBED1 | 6.64e-05 | 616 | 195 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | ABCC4 ATR ACHE MATN4 BRPF1 ABCG5 RAD23B VIM MSH3 TXNRD2 AAAS MYH14 PRKDC ZBED1 | 6.64e-05 | 616 | 195 | 14 | C0376358 |
| Disease | obsolete_red blood cell distribution width | KMT2B ATR CDH23 BCKDHA LONP1 CYFIP1 DENND1B A4GALT YDJC VIM ABCC1 P4HA2 RBBP5 PCDHGA5 PKD2L1 APOB FREM3 PRMT6 NOL4L CCT5 FARS2 LYN | 8.96e-05 | 1347 | 195 | 22 | EFO_0005192 |
| Disease | Malignant neoplasm of breast | ACHE SRC OBSCN ACY1 PTGS1 MTMR3 FASTKD3 AGAP2 VIM ABCC1 VWF DYNC2H1 UBR4 GRIN2D SPAG6 COTL1 CCT5 P3H2 PRODH | 1.00e-04 | 1074 | 195 | 19 | C0006142 |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 1.30e-04 | 3 | 195 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | ABCC4 ZNF862 L2HGDH ACY1 FZD9 A4GALT ABCC1 NAT8B PYROXD2 NAT8 PKD2L1 APOB GRIK5 MROH1 DNAH17 PRODH PHACTR1 | 1.93e-04 | 945 | 195 | 17 | EFO_0005653 |
| Disease | Nonsyndromic Deafness | 2.04e-04 | 81 | 195 | 5 | C3711374 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 2.58e-04 | 4 | 195 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 4.29e-04 | 5 | 195 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 4.29e-04 | 5 | 195 | 2 | C2608084 | |
| Disease | N2-acetyl,N6-methyllysine measurement | 4.29e-04 | 5 | 195 | 2 | EFO_0800109 | |
| Disease | 14-3-3 protein beta/alpha measurement | 4.29e-04 | 5 | 195 | 2 | EFO_0021957 | |
| Disease | migraine without aura | 4.29e-04 | 5 | 195 | 2 | MONDO_0100431 | |
| Disease | N-acetylglutamate measurement | 4.29e-04 | 5 | 195 | 2 | EFO_0800005 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 4.29e-04 | 5 | 195 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Hereditary hearing loss and deafness | 4.35e-04 | 146 | 195 | 6 | cv:C0236038 | |
| Disease | JT interval, response to sulfonylurea | 4.57e-04 | 23 | 195 | 3 | EFO_0007885, EFO_0007922 | |
| Disease | VACTERL association (implicated_via_orthology) | 6.40e-04 | 6 | 195 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 6.40e-04 | 6 | 195 | 2 | C0079301 | |
| Disease | Prolactinoma | 6.40e-04 | 6 | 195 | 2 | C0033375 | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 6.40e-04 | 6 | 195 | 2 | DOID:13809 (is_marker_for) | |
| Disease | migraine disorder, pulse pressure measurement | 6.61e-04 | 26 | 195 | 3 | EFO_0005763, MONDO_0005277 | |
| Disease | Liver Cirrhosis, Experimental | ACHE TOR4A PTGS1 AGL CSAD ABCG5 VIM VWF NUDT16 NAT8 COTL1 STAU2 MYO1F PRODH | 6.76e-04 | 774 | 195 | 14 | C0023893 |
| Disease | Ciliopathies | 8.36e-04 | 110 | 195 | 5 | C4277690 | |
| Disease | Common Migraine | 8.93e-04 | 7 | 195 | 2 | C0338480 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 8.93e-04 | 7 | 195 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | lifestyle measurement, alcohol consumption measurement | 1.02e-03 | 115 | 195 | 5 | EFO_0007878, EFO_0010724 | |
| Disease | HDL cholesterol change measurement, response to simvastatin, response to fenofibrate | 1.19e-03 | 8 | 195 | 2 | EFO_0007805, GO_1901557, GO_1903491 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 1.46e-03 | 34 | 195 | 3 | EFO_0009926 | |
| Disease | pulse pressure measurement, migraine without aura, susceptibility to, 4 | 1.52e-03 | 9 | 195 | 2 | EFO_0005763, MONDO_0011847 | |
| Disease | N-acetylleucine measurement | 1.52e-03 | 9 | 195 | 2 | EFO_0800116 | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 1.52e-03 | 9 | 195 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | platelet component distribution width | CAPN12 ZZEF1 CYFIP1 DGAT2 A4GALT PREX1 BRWD1 VWF POGK NOL4L P2RY2 P3H2 LYN | 1.62e-03 | 755 | 195 | 13 | EFO_0007984 |
| Disease | Nonsyndromic genetic hearing loss | 1.64e-03 | 76 | 195 | 4 | cv:C5680182 | |
| Disease | preeclampsia | 1.80e-03 | 78 | 195 | 4 | EFO_0000668 | |
| Disease | Drug toxicity | 2.36e-03 | 84 | 195 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 2.36e-03 | 84 | 195 | 4 | C0041755 | |
| Disease | kidney disease (implicated_via_orthology) | 2.52e-03 | 41 | 195 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | fatty acid measurement | 2.58e-03 | 436 | 195 | 9 | EFO_0005110 | |
| Disease | N-acetyl-2-aminooctanoate measurement | 2.75e-03 | 12 | 195 | 2 | EFO_0800567 | |
| Disease | Intellectual Disability | 3.05e-03 | 447 | 195 | 9 | C3714756 | |
| Disease | resting heart rate | 3.18e-03 | 149 | 195 | 5 | EFO_0004351 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 3.23e-03 | 13 | 195 | 2 | C1846647 | |
| Disease | 3-carboxy-4-methyl-5-propyl-2-furanpropanoate CMPF measurement | 3.23e-03 | 13 | 195 | 2 | EFO_0021053 | |
| Disease | N-acetylglutamine measurement | 3.23e-03 | 13 | 195 | 2 | EFO_0800017 | |
| Disease | Leber congenital amaurosis (implicated_via_orthology) | 3.23e-03 | 13 | 195 | 2 | DOID:14791 (implicated_via_orthology) | |
| Disease | dystonia (is_implicated_in) | 3.75e-03 | 14 | 195 | 2 | DOID:543 (is_implicated_in) | |
| Disease | Pneumoconiosis | 3.75e-03 | 14 | 195 | 2 | C0032273 | |
| Disease | Bagassosis | 3.75e-03 | 14 | 195 | 2 | C0004681 | |
| Disease | asymmetric dimethylarginine measurement | 3.75e-03 | 14 | 195 | 2 | EFO_0010463 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 3.75e-03 | 14 | 195 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 3.87e-03 | 156 | 195 | 5 | DOID:10283 (is_marker_for) | |
| Disease | unipolar depression, bipolar disorder | 3.87e-03 | 156 | 195 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | economic and social preference | 3.97e-03 | 97 | 195 | 4 | EFO_0004827 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 4.27e-03 | 99 | 195 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 4.31e-03 | 15 | 195 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | N,N,N-trimethyl-5-aminovalerate measurement | 4.31e-03 | 15 | 195 | 2 | EFO_0800090 | |
| Disease | triacylglycerol 52:3 measurement | 4.31e-03 | 15 | 195 | 2 | EFO_0010415 | |
| Disease | response to statin, LDL cholesterol change measurement | 4.31e-03 | 15 | 195 | 2 | EFO_0007804, GO_0036273 | |
| Disease | epilepsy (implicated_via_orthology) | 4.65e-03 | 163 | 195 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 4.69e-03 | 51 | 195 | 3 | cv:CN043650 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 4.91e-03 | 16 | 195 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Keratoderma, Palmoplantar | 4.91e-03 | 16 | 195 | 2 | C4551675 | |
| Disease | Blood Platelet Disorders | 4.91e-03 | 16 | 195 | 2 | C0005818 | |
| Disease | 2-hydroxyglutarate measurement | 4.91e-03 | 16 | 195 | 2 | EFO_0021506 | |
| Disease | migraine without aura, susceptibility to, 4 | 4.91e-03 | 16 | 195 | 2 | MONDO_0011847 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 5.13e-03 | 315 | 195 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | diastolic blood pressure, systolic blood pressure | SPEG GPR135 PIDD1 ADCY1 QSOX1 DENND1B DYNC2H1 SPAG6 TENM4 GUCY2D LRP1 | 5.20e-03 | 670 | 195 | 11 | EFO_0006335, EFO_0006336 |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 5.27e-03 | 239 | 195 | 6 | EFO_0010934 | |
| Disease | serum alanine aminotransferase measurement | L2HGDH FZD9 DGLUCY ABCG5 BRWD1 RBBP5 PKD2L1 APOB CYFIP2 PRMT6 ZC3H7A TENM4 P2RY2 | 5.35e-03 | 869 | 195 | 13 | EFO_0004735 |
| Disease | retinopathy | 5.54e-03 | 17 | 195 | 2 | EFO_0003839 | |
| Disease | Dystonia, Limb | 5.54e-03 | 17 | 195 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 5.54e-03 | 17 | 195 | 2 | C0393610 | |
| Disease | cervical artery dissection | 5.54e-03 | 17 | 195 | 2 | EFO_1000059 | |
| Disease | Drug-Induced Liver Disease | 5.64e-03 | 404 | 195 | 8 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 5.64e-03 | 404 | 195 | 8 | C3658290 | |
| Disease | Hepatitis, Toxic | 5.64e-03 | 404 | 195 | 8 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 5.64e-03 | 404 | 195 | 8 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 5.64e-03 | 404 | 195 | 8 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 5.64e-03 | 404 | 195 | 8 | C1262760 | |
| Disease | Dystonia, Paroxysmal | 6.20e-03 | 18 | 195 | 2 | C0393588 | |
| Disease | Hypercholesterolemia, Familial | 6.20e-03 | 18 | 195 | 2 | C0020445 | |
| Disease | heart rate response to recovery post exercise | 6.40e-03 | 57 | 195 | 3 | EFO_0009185 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDVYDGRFLVQAERT | 161 | P22303 | |
| DFAGDLDYNELAVRV | 1366 | Q9UMD9 | |
| TVFYRAAVRLRDQGG | 646 | O95696 | |
| FAVALLDDSVRVYNA | 166 | Q9NRG9 | |
| AAAVLRAEAEKGRQY | 686 | P0C7U0 | |
| LARGVAELSLADYAF | 261 | P22674 | |
| QSRYVLNGAFLAFER | 211 | Q9NPC4 | |
| NEAANFDLAVATRRY | 101 | P0C2W7 | |
| TRVEGGFDQYRALLQ | 686 | Q9NUQ8 | |
| AYDDVFRGRTNAAEI | 6091 | Q8WXG9 | |
| DVAARDAQGRTALFY | 1116 | Q99490 | |
| RDAFRKIAGDYAIEA | 226 | A6QL64 | |
| ADAVREGRNQYLETF | 121 | P46597 | |
| DDAGQFAVALVIIYR | 2331 | Q9NYQ6 | |
| VLAVANEEGFVRLYN | 66 | Q9NZJ0 | |
| QRGLSAVRDFAREYV | 236 | Q86WK7 | |
| GRVQLAVAEEFDLYN | 466 | Q86WK7 | |
| LDRVVRRYAEVADAG | 181 | Q9H7Y0 | |
| NGELVYRIEAGAQDR | 2101 | Q9H251 | |
| YRIEAGAQDRFLIHL | 2106 | Q9H251 | |
| RFRLALGSFVEEYNN | 31 | P61962 | |
| RAFQYADGLEQLRGA | 286 | Q9BU89 | |
| LGNNAAYAFNRDIIR | 146 | Q9UH62 | |
| AYAFNRDIIRDLGGL | 151 | Q9UH62 | |
| ELAQYREVAAFAQFG | 436 | P25705 | |
| AAAAIVFLVDRFLYG | 106 | Q96QP1 | |
| RAFFYVAAQLVGAIA | 86 | P55064 | |
| YEDFNVQLRRGLVGS | 111 | Q9HC84 | |
| GYEREQVIAALRASF | 201 | P54727 | |
| IDGFFARNNEEYLAL | 176 | O00391 | |
| YEAENLARLQRAFAR | 151 | P49758 | |
| FARDADVGVNSLRSY | 156 | Q9Y5G8 | |
| LDYEALQAFEFRVGA | 521 | Q9Y5E7 | |
| IAALYARFTAQIRGA | 86 | O00255 | |
| FAYNLDQDNARVGDR | 171 | Q6ZNF0 | |
| EAANFDLAVVARRYP | 101 | Q5JQC4 | |
| FEDRNAFVTGIARYI | 46 | Q7L576 | |
| YRFFGEDAEIAAREL | 256 | P20585 | |
| QYALNIAFSEAEGAR | 141 | O00339 | |
| EVAAQARARGIEIYA | 156 | O95460 | |
| RAALVRAAGTLEDVY | 261 | A6NH11 | |
| LGEAAAAFRVERTDY | 81 | Q96DE0 | |
| YDAVFLLARGVAEAR | 351 | Q02846 | |
| GIVDYRQVALSFAQD | 191 | Q9H9P8 | |
| YDFALVNIGRLEAVS | 96 | A4FU01 | |
| RLLTDRASYGEAQAV | 221 | P22083 | |
| FDVIEVARLNGSFRY | 1986 | Q07954 | |
| QTFLVNDLAAGRAYD | 476 | Q9P244 | |
| YQTRDDFVRGLLVNE | 266 | Q13144 | |
| IIVSFQAAARGYLAR | 806 | Q7Z406 | |
| QILAAAAAERDVVYF | 886 | Q86W56 | |
| ARRALYNAGVVDLVS | 326 | Q8WY64 | |
| IARALNREYFRFSVG | 536 | P36776 | |
| RQAGAEALSQAVARY | 1176 | Q92616 | |
| DVLRRVYVDFEGINF | 1701 | Q9UMN6 | |
| EAFGFEQAARDYTLR | 366 | Q9UGL1 | |
| YFNELSSEGRQVLRD | 871 | Q86UT6 | |
| NGRFALVDQRVAEYV | 256 | Q9P215 | |
| YRATAGVEALQLVDR | 191 | Q8IVL5 | |
| ASDLDIGANAQLRYR | 156 | Q9Y5H7 | |
| AELGARALEFTNIYV | 181 | Q4VXU2 | |
| YGVEALVDAFSRQIA | 416 | P23219 | |
| FEDRNAFVTGIARYI | 46 | Q96F07 | |
| AVRQLIAGYRESAAF | 406 | Q96MY1 | |
| RFSEGALEYLANLDR | 191 | Q8NDA8 | |
| YFLAGQRLVRFARDA | 306 | P41231 | |
| NEATAAAIAYGLDRR | 176 | P48741 | |
| SDLNVVASFDRRGEY | 151 | Q15291 | |
| ERAGGNLRYFEQLLE | 241 | O15460 | |
| YLAEARISFNLGAAE | 71 | Q9C0D0 | |
| IYFEAGDQRASAALR | 3076 | Q5VST9 | |
| AAFEQYLEFLVGRVQ | 5776 | Q5VST9 | |
| ARVNLARAVYQDADI | 541 | O15439 | |
| DRSAEGRALYAVAQR | 66 | Q96EF6 | |
| AIGRREALNVFGNDY | 216 | Q14376 | |
| VYSLAFLIRAVAGAQ | 276 | O00144 | |
| RRALDVATFAAGYLL | 181 | O60755 | |
| LRAGYNIIDRLFDGA | 3896 | Q8NCM8 | |
| EALFRGYTLRLEQAA | 46 | Q08828 | |
| YQGAIRQIDDIDVRF | 4116 | P04114 | |
| NAGESRLAELYVERA | 1946 | Q13535 | |
| AGRLQLFRGQSYEAI | 21 | Q6ZSI9 | |
| GSAVVADLRNYFDEQ | 376 | Q5T8I9 | |
| NREEGYRTRNVDAFL | 401 | Q8IZ08 | |
| IRFYQLGDEALAAFR | 121 | P17658 | |
| LFYREVADGANAIVL | 111 | Q9BXC9 | |
| RAAYNLVRDDGSAVI | 11 | Q14019 | |
| AFARLEEGYENAIRD | 1711 | Q9UFH2 | |
| YAATRREGFNDVVRG | 361 | Q9H0R6 | |
| GAYRARALELEAEVA | 241 | Q01850 | |
| LGRAYALAFAERGAL | 21 | P51659 | |
| FYNEARARARANRGI | 196 | Q9NNZ3 | |
| AARAALRVYAVGAAV | 6 | Q8N5I4 | |
| TVRAVDALAALQDFY | 296 | Q96C10 | |
| VQARGRARADQSVYA | 466 | Q96C10 | |
| ARYAARLAAEAGNVT | 406 | O60941 | |
| GEVYVNGRALRREQF | 111 | Q9H222 | |
| VIAAARDGYDAERAQ | 96 | Q02410 | |
| AQAGARRVYAVEASA | 101 | Q96LA8 | |
| AENNFEVELNYGLRR | 2081 | Q9NSI6 | |
| GLERRIDQAFVLARY | 376 | Q9Y600 | |
| FIREAQRADSGRYQL | 111 | A2RUH7 | |
| ELVDYFLNVATAQGR | 291 | O00754 | |
| FGLARVIEDNEYTAR | 386 | P07948 | |
| FGGDEISRQQYRRAL | 1986 | Q8TEP8 | |
| IYGGRVDNEFDQRLL | 4251 | Q14204 | |
| LAGSRYDSDRDIQFL | 836 | Q86Z14 | |
| QTYDADLREQALRFG | 586 | Q13751 | |
| RRADVYVGVDVFARG | 321 | Q8NFI3 | |
| LVAIERAGRAADGNY | 431 | Q7Z3D6 | |
| ARDFLDEYIFLAVGR | 391 | O15523 | |
| EEGIARVLNSRYAFL | 706 | Q16478 | |
| DLRRLYSVDAQGFLD | 2131 | O95180 | |
| LRAQAALFGSYRDAL | 331 | Q6P3S1 | |
| RYLAGEVAESADIAR | 126 | A6NKF1 | |
| LVYNARIVGRDAADF | 1901 | Q6ZTR5 | |
| AVEQRVASYEEFRGI | 36 | Q8IW40 | |
| FAFDEIVALGYRENV | 111 | P48444 | |
| AAYSGVLRGERQAEA | 6 | Q96PD7 | |
| GRAEDAIIALSNYRL | 46 | Q13615 | |
| DREAQAVRGQVSFYR | 711 | Q9HB75 | |
| AALDNTDLVFGQYRE | 146 | P12694 | |
| LARDGAFAEFLRTYA | 856 | P33527 | |
| EALVARGRDAFYEVL | 36 | A6ND36 | |
| RFTQEDLINGRVAYA | 1006 | P0C091 | |
| ARLIEDNEYTARQGA | 411 | P12931 | |
| GRLANYNDDLAEAVV | 66 | O75602 | |
| FALYEQRGAQERALA | 446 | Q7Z736 | |
| GALAFEDIYIEQRRV | 1046 | P35499 | |
| NNARYLREADFARVA | 66 | Q8WUY1 | |
| GRELTEANRFAYAAL | 31 | Q5TGY1 | |
| GIDRVYEIGRQFRNE | 311 | Q15046 | |
| RLREQDANAAGLYFT | 61 | Q5TGI4 | |
| AFYVLEQQRVGFAVD | 1391 | Q6P3W6 | |
| RSAFYVLEQQRVGLA | 386 | Q8N660 | |
| RSAFYVLEQQRVGLA | 386 | A0A087WUL8 | |
| RSAFYVLEQQRVGLA | 286 | P0DPF2 | |
| RSAFYVLEQQRVGLA | 1506 | P0DPF2 | |
| RSAFYVLEQQRVGLA | 2726 | P0DPF2 | |
| RSAFYVLEQQRVGLA | 3946 | P0DPF2 | |
| AVDLFRNAGYAVSLR | 81 | P57105 | |
| NEELRRVLEAFIYFG | 331 | Q14CZ7 | |
| FVAYRNGRVDEAVSL | 31 | A1A4F0 | |
| YVSRAAREELLAEFG | 3611 | P58107 | |
| FQAFRSRREEALGLY | 771 | Q8TCU6 | |
| LVRGAYLAQERARAA | 441 | O43272 | |
| YLAQERARAAEIGYE | 446 | O43272 | |
| VLRARALVAFQRGEY | 126 | Q8N196 | |
| LQRAGRSEAVVEYVF | 521 | Q7KZF4 | |
| IRIADGYEQAARVAI | 131 | P48643 | |
| AVYFARDVRNSEVVA | 41 | Q9UL54 | |
| TLYIGAREAVFAVNA | 61 | Q92854 | |
| TFLLDAVRNRRAGYE | 51 | O60518 | |
| AARADLAAQYTTVGR | 231 | P51688 | |
| INAVRQLVAGYRESA | 606 | O94818 | |
| QLVAGYRESAAFLLR | 611 | O94818 | |
| DTIFYRAAVRLREQG | 711 | P55201 | |
| NDDARTELYRSLFGQ | 536 | Q9NY61 | |
| YGAAVAFFEETARQL | 31 | Q03154 | |
| YVAQNAARIVRALFE | 1081 | Q8N3C0 | |
| RAEGLYLFENGQRVS | 246 | Q9Y240 | |
| NFALLQEGEVYSADR | 2316 | Q6P2Q9 | |
| AEASALYGRALRVLQ | 26 | Q15785 | |
| AQRDLYREVTLENFG | 66 | Q8N9K5 | |
| DGEFTAVVYRLIRNA | 11 | Q8N4P2 | |
| LRIQQVVRGDSAAYF | 96 | A0A087X0M5 | |
| LENYGNVFSLDRETR | 81 | P17036 | |
| GIGDRYDAAQLRILA | 1826 | P04275 | |
| GDAARQGVYENFRRE | 376 | Q13009 | |
| AEERAQRLAQAASLY | 736 | O15020 | |
| AGERARALEAALALY | 841 | O15020 | |
| VSLARAQGSVAFDYR | 2276 | O15020 | |
| RLRILAAERGDAGFY | 926 | Q15772 | |
| EYLARIQGFQAALSA | 501 | Q9NUL3 | |
| AAALDSFQARRYVAA | 536 | P41226 | |
| AYLQRLGVNTAVFER | 51 | Q8N2H3 | |
| IDTAVFDYLIGNADR | 276 | O75063 | |
| EYERAVVFRLGRIQA | 56 | Q8TAV4 | |
| ASYAAEERIEGRVAA | 636 | Q9H269 | |
| FAVEAANYQDTIGRL | 351 | P08670 | |
| LRGFVDEIRSQYRAD | 286 | Q969P6 | |
| QLRVDLDTADFGYAV | 141 | Q9BU02 | |
| VFAEALQAYGVRFTR | 146 | A8MPS7 | |
| DAQEARTVREALGRY | 6 | Q2TAL5 | |
| ALGRYEAALEGAVRA | 16 | Q2TAL5 | |
| EYDQAGRITSRIFAD | 1906 | Q6N022 | |
| VLAFQRYQIGADSAL | 166 | O43759 | |
| LAQALAAEGYYDIRR | 491 | Q9H254 | |
| EREGSIYLNDFARVV | 1676 | Q9NY15 | |
| AAYDLRQGQEALARL | 106 | Q15814 | |
| ESVRRAAQQYGFREG | 71 | Q8N841 | |
| QFRIILGDFDYNAID | 516 | Q9P0L9 | |
| VGRAFARALRQEFAA | 16 | Q9Y3D7 | |
| LGASLAFNNIYREFR | 1076 | P78527 | |
| LTGIEYLQQRFDADR | 926 | O60290 | |
| AQLSFYRVAGREFAV | 396 | Q9NXH8 | |
| ALVRNLFNEGNDVYR | 41 | Q8IWR0 | |
| GVLRLDADAAQRVVY | 261 | Q9H1Z9 | |
| RGAAAGQRDYDLLVV | 31 | Q9NNW7 | |
| RAVRDYLFRVNEATA | 2601 | O43149 | |
| QARDLFAQIAGAVRY | 111 | Q9BXA6 | |
| NREALYGVFDGDRNV | 1201 | O60346 | |
| RLAEYFIGDVFAARF | 566 | Q96QU8 | |
| VDEQVFLYENARSGA | 641 | O96006 | |
| AGLDAFLVVGDVYRR | 166 | O95363 | |
| IRELFDYNLRRGAAA | 3906 | Q5T4S7 | |
| AALRSRFELEYALNA | 761 | Q59H18 | |
| RDFNVGDYIQAVLDR | 256 | P06737 | |
| AFAEQFLRGSDYAIR | 981 | P01266 | |
| YEGDRNESAVFVAIR | 61 | Q04912 | |
| DYNLIVIERGAAAAA | 516 | Q13263 | |
| NSFAVTGYDLAEIRR | 316 | Q9H977 | |
| FALLERFSGYREDNI | 286 | P07101 | |
| RYVEARNIILAFAGT | 1116 | P35573 | |
| DGNYARVESVDLLAF | 291 | O00160 | |
| YAERRGDAATIVALR | 496 | Q96BF6 | |
| ALVRTVLQFARDQGY | 156 | Q9UHF3 | |
| ALVRTVLQFARDQGY | 156 | Q9UHE5 | |
| VVARGAQALLRDYGF | 326 | O15399 |